title: [Prevalence of hepatitis G virus among Tunisian blood donors].
abstract: Prevalence of hepatitis G virus among Tunisian blood donors Hepatitis G virus (GBV-C/HGV) is a recently identified virus which occurs worldwide. The prevalence of GBV-C/HGV in Tunisia has not been previously studied. We aimed to assess the prevalence of GBV-C/HGV infection in Tunisian blood donors. A total of 912 blood donors were tested for anti-E2 antibodies of GBV-C/HGV by enzyme-linked immunosorbent assay and 600 were tested by reverse transcriptase polymerase chain reaction. GBV-C/HGV RNA was found in 5.3% of the sample and HGV antibodies occurred in 4.9%. A correlation was noticed between GBV-C/HGV infection and hepatitis C virus (P = 0.006). The prevalence of GBV-C/HGV is similar to that reported worldwide.
authors.affiliation: Faculté de pharmacie, Université de Monastir, Tunisie.
authors.forename: M
authors.initials: M
authors.lastname: Mastouri
authors.forename: I L
authors.initials: IL
authors.lastname: Safer
authors.forename: B
authors.initials: B
authors.lastname: Pozzetto
authors.forename: T
authors.initials: T
authors.lastname: Bourlet
authors.forename: M
authors.initials: M
authors.lastname: Khedher
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D001782:Blood Donors / Q000706:statistics & numerical data*; D015897:Comorbidity; D004279:DNA, Viral / Q000032:analysis / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D029407:GB virus C / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000150:complications / Q000453:epidemiology; D006508:Hepatitis Antibodies / Q000097:blood; D006509:Hepatitis B / Q000150:complications / Q000453:epidemiology; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology; D006525:Hepatitis, Viral, Human / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000821:virology*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D011159:Population Surveillance; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D014416:Tunisia / Q000453:epidemiology
chemical_list: D004279:DNA, Viral; D006508:Hepatitis Antibodies; D012367:RNA, Viral